Source: Abstracts. Conference titles: World Congress of Gynaecology and Obstetrics (Figo). Unidade: FM
Assunto: GINECOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HEGG, Roberto et al. Droloxifene (drol) a new antietrogen in advanced breast cancer , double blind dose finding study (for the drl 002 international study). 1991, Anais.. Limerick: International Journal of Gynecology and Obstetrics, 1991. . Acesso em: 06 nov. 2024.APA
Hegg, R., Aguiar, L. F., Souza, A. Z. de, Teixeira, L. C., Malzyner, A., Deschenes, L., et al. (1991). Droloxifene (drol) a new antietrogen in advanced breast cancer , double blind dose finding study (for the drl 002 international study). In Abstracts. Limerick: International Journal of Gynecology and Obstetrics.NLM
Hegg R, Aguiar LF, Souza AZ de, Teixeira LC, Malzyner A, Deschenes L, Pritchard KI, Pinotti JA. Droloxifene (drol) a new antietrogen in advanced breast cancer , double blind dose finding study (for the drl 002 international study). Abstracts. 1991 ;[citado 2024 nov. 06 ]Vancouver
Hegg R, Aguiar LF, Souza AZ de, Teixeira LC, Malzyner A, Deschenes L, Pritchard KI, Pinotti JA. Droloxifene (drol) a new antietrogen in advanced breast cancer , double blind dose finding study (for the drl 002 international study). Abstracts. 1991 ;[citado 2024 nov. 06 ]
